Bank of New York Mellon’s Johnson & Johnson JNJ Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2015
Q4
Sell
-13,100
Closed -$1.22M 4364
2015
Q3
$1.22M Buy
13,100
+12,977
+10,550% +$1.26M ﹤0.01% 3060
2015
Q2
$12K Buy
+123
New +$12.3K ﹤0.01% 4252
2014
Q2
Sell
-64
Closed -$6K 4209
2014
Q1
$6K Sell
64
-1,049
-94% -$97.3K ﹤0.01% 4168
2013
Q4
$102K Buy
1,113
+109
+11% +$10K ﹤0.01% 4010
2013
Q3
$87K Buy
1,004
+4
+0.4% +$359 ﹤0.01% 3981
2013
Q2
$86K Buy
+1,000
New +$84.9K ﹤0.01% 3959

Other funds holding JNJ

Bank of New York Mellon's JNJ Position: Q2 2026 in Review

Bank of New York Mellon reduced its Johnson & Johnson (JNJ) stake by 0.64% in Q2 2026, selling an estimated $32.3M and leaving 21,683,347 shares worth $5.51B. The position accounts for 0.9% of the portfolio, ranked #15.

Bank of New York Mellon first reported a position in JNJ in Q2 2013 and has held it in 53 quarters since. The position peaked at $5.69B in Q2 2022. 3,841 funds tracked by Wall St. Rank hold JNJ as of Q2 2026.

  • Bank of New York Mellon held 21,683,347 shares of Johnson & Johnson worth $5.51B as of Q2 2026.
  • Bank of New York Mellon sold 138,615 Johnson & Johnson shares in Q2 2026, an estimated $32.3M.
  • Johnson & Johnson made up 0.9% of Bank of New York Mellon's portfolio in Q2 2026, its #15 holding.
  • Bank of New York Mellon first reported a position in Johnson & Johnson in Q2 2013 and has held it in 53 quarters since.
  • Bank of New York Mellon's Johnson & Johnson position peaked at $5.69B in Q2 2022.
  • 3,841 funds tracked by Wall St. Rank held Johnson & Johnson as of Q2 2026.

Based on Bank of New York Mellon's 13F filing for Q2 2026, filed 6 Aug 2026.